Bartlett & Co Wealth Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51.6M | Sell |
203,823
-3,138
| -2% | -$850K | 0.66% | 41 |
|
|
2025
Q4 | $51.9M | Sell |
206,961
-1,249
| -0.6% | -$332K | 0.68% | 43 |
|
|
2025
Q3 | $59.8M | Sell |
208,210
-2,595
| -1% | -$695K | 0.79% | 35 |
|
|
2025
Q2 | $55.3M | Buy |
210,805
+1,785
| +0.9% | +$435K | 0.77% | 38 |
|
|
2025
Q1 | $48.6M | Sell |
209,020
-2,164
| -1% | -$525K | 0.72% | 45 |
|
|
2024
Q4 | $48.4M | Sell |
211,184
-736
| -0.3% | -$169K | 0.7% | 44 |
|
|
2024
Q3 | $47.4M | Buy |
211,920
+2,723
| +1% | +$598K | 0.68% | 43 |
|
|
2024
Q2 | $42.6M | Sell |
209,197
-12,544
| -6% | -$2.55M | 0.65% | 46 |
|
|
2024
Q1 | $48.4M | Sell |
221,741
-946
| -0.4% | -$208K | 0.75% | 43 |
|
|
2023
Q4 | $50.6M | Buy |
222,687
+4,375
| +2% | +$919K | 0.82% | 42 |
|
|
2023
Q3 | $43.9M | Sell |
218,312
-25,186
| -10% | -$5.31M | 0.79% | 43 |
|
|
2023
Q2 | $50.5M | Buy |
243,498
+3,759
| +2% | +$729K | 0.87% | 35 |
|
|
2023
Q1 | $47.3M | Buy |
239,739
+2,920
| +1% | +$601K | 0.91% | 35 |
|
|
2022
Q4 | $47.9M | Buy |
236,819
+15,472
| +7% | +$3.02M | 0.96% | 34 |
|
|
2022
Q3 | $38.9M | Buy |
221,347
+7,435
| +3% | +$1.52M | 0.84% | 39 |
|
|
2022
Q2 | $43.1M | Buy |
213,912
+16,853
| +9% | +$3.59M | 0.87% | 41 |
|
|
2022
Q1 | $44.6M | Buy |
197,059
+2,001
| +1% | +$471K | 0.78% | 43 |
|
|
2021
Q4 | $52.7M | Buy |
195,058
+4,392
| +2% | +$1.09M | 0.89% | 37 |
|
|
2021
Q3 | $46.1M | Sell |
190,666
-8,797
| -4% | -$2.22M | 0.88% | 42 |
|
|
2021
Q2 | $47.3M | Sell |
199,463
-12,250
| -6% | -$2.79M | 0.9% | 43 |
|
|
2021
Q1 | $46.4M | Buy |
211,713
+620
| +0.3% | +$124K | 0.93% | 39 |
|
|
2020
Q4 | $36.9M | Buy |
211,093
+6,593
| +3% | +$1.14M | 0.79% | 45 |
|
|
2020
Q3 | $33.1M | Buy |
204,500
+920
| +0.5% | +$146K | 0.78% | 47 |
|
|
2020
Q2 | $29.1M | Buy |
203,580
+2,607
| +1% | +$361K | 0.76% | 45 |
|
|
2020
Q1 | $21.8M | Sell |
200,973
-1,095
| -0.5% | -$158K | 0.66% | 46 |
|
|
2019
Q4 | $29.4M | Sell |
202,068
-7,911
| -4% | -$1.14M | 0.72% | 45 |
|
|
2019
Q3 | $30.3M | Buy |
209,979
+2,366
| +1% | +$345K | 0.8% | 42 |
|
|
2019
Q2 | $30.8M | Buy |
207,613
+523
| +0.3% | +$73K | 1.15% | 33 |
|
|
2019
Q1 | $27.2M | Buy |
207,090
+9,735
| +5% | +$1.2M | 1.04% | 36 |
|
|
2018
Q4 | $21.4M | Buy |
197,355
+5,026
| +3% | +$673K | 0.91% | 44 |
|
|
2018
Q3 | $28.7M | Buy |
192,329
+16,182
| +9% | +$2.46M | 1.08% | 36 |
|
|
2018
Q2 | $27.2M | Buy |
176,147
+161
| +0.1% | +$24.3K | 1.1% | 34 |
|
|
2018
Q1 | $24.5M | Buy |
+175,986
| New | +$25.9M | 1.01% | 40 |
|
Other funds holding LH
VCM
VPM
Bartlett & Co Wealth Management's LH Position: Q1 2026 in Review
Bartlett & Co Wealth Management reduced its Labcorp (LH) stake by 1.5% in Q1 2026, selling an estimated $850K and leaving 203,823 shares worth $51.6M. The position accounts for 0.66% of the portfolio, ranked #41.
Bartlett & Co Wealth Management first reported a position in LH in Q1 2018 and has held it in 33 quarters since. The position peaked at $59.8M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Bartlett & Co Wealth Management held 203,823 shares of Labcorp worth $51.6M as of Q1 2026.
- Bartlett & Co Wealth Management sold 3,138 Labcorp shares in Q1 2026, an estimated $850K.
- Labcorp made up 0.66% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #41 holding.
- Bartlett & Co Wealth Management first reported a position in Labcorp in Q1 2018 and has held it in 33 quarters since.
- Bartlett & Co Wealth Management's Labcorp position peaked at $59.8M in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.